China's first Mpox vaccine gets clinical approval

2024-09-09 10:05:43

Asia Tech Wire (Sep 9) -- China's first monkeypox vaccine received clinical approval.

Chinese state-owned pharmaceutical group Sinopharm on Monday received a clinical trial notification letter from the National Medical Products Administration (NMPA) for its live attenuated Mpox vaccine against the MVA strain.

The vaccine is the first monkeypox vaccine that China has approved for clinical trials.

Sinopharm said the safety and efficacy of the vaccine strain has been fully demonstrated by clinical data.

Vaccine

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Huawei's Automotive BU spin-off is in the countdown, and old employees are expected to receive extra compensation when they transfer to other companies? Insider: I haven't heard of it.
                            2024-12-27

                                    Tesla's (TSLA.O) shares fell as much as 5% in pre-market trading after its fourth-quarter deliveries fell short of expectations.
                            2025-01-02

                                    Tesla (TSLA.O) produced 22,727 other models in the fourth quarter, compared with market forecasts of 22,790.
                            2025-01-02

                                    Yunding Technology: The company currently has no self-owned AI hardware products for sale
                            2025-01-02

                                    Henan Provincial Development and Reform Commission held a symposium on the development of new energy vehicle industry
                            2024-12-27